Although the first evidence on the potential link between PPARγ and intestinal disease established a correlation between this receptor expression and an increase in colon tumorigenesis, recently, many researchers have re-examined the association between PPARγ and the risk of colorectal cancer (CRC) [35,36,37,38]. Here, PPARG is linked to colorectal cancer.